Investing in dividend ETFs can provide exposure to stocks with higher dividend payments, potentially building a passive income stream worth
FERGUSON PLC (FERG) has received a high rating from Validea’s guru fundamental report, particularly based on the strategy of Pim
Validea’s guru fundamental report for Williams Companies Inc (WMB) shows that the stock rates highest in the P/E/Growth Investor model
Validea’s guru fundamental report for HOWMET AEROSPACE INC (HWM) shows that it rates highest using the Twin Momentum Investor model.
Validea’s guru fundamental report for EQT CORP (EQT) shows it rates highest using the Acquirer’s Multiple Investor model by Tobias
Validea’s guru fundamental report for Cummins Inc. (CMI) shows it rates highest using the Multi-Factor Investor model based on Pim
Lexicon Pharmaceuticals, Inc. presented new sotagliflozin clinical data at the AHA Annual Scientific Sessions 2025, showing benefits for heart failure
A battle for control of chipmaker Nexperia has disrupted the global auto supply chain, forcing Honda to halt production of
Realty Income has raised its monthly dividend 132 times over the past three decades, with a current yield of 5.8%.
Summary: QLD and SPXL are both leveraged ETFs that aim to provide amplified returns. QLD tracks the Nasdaq-100 index while
e.l.f. Beauty shares plummeted after the company’s guidance fell far below expectations, attributed to tariff pressure. Despite this, the long-term
Palantir Technologies (PLTR) has had a stellar quarter, with record government contracts, surging U.S. commercial growth, and impressive profitability metrics
Jeremy Keil, a certified financial planner, offers retirement planning advice in his book “Retire Today: Create Your Retirement Master Plan
Vor Bio’s telitacicept treatment shows significant reduction in proteinuria in adults with IgA nephropathy (IgAN) after 39 weeks, with a
Monte Rosa Therapeutics presents promising preclinical data on MRT-8102, a potential treatment for cardiovascular and cardiometabolic diseases at the American
MyPEAK-1 data on TN-201 gene therapy for hypertrophic cardiomyopathy presented at AHA Scientific Sessions 2025 show promising results with improved
Zinzino has agreed to acquire key business assets from Sanki, a direct sales company based in Mexico. This includes the
Oklo, a small modular nuclear reactor company, went public in 2024 through a special purpose acquisition company co-founded by Sam
Jade Biosciences, Inc. presented two posters for JADE101, its investigational anti-APRIL monoclonal antibody for treating IgAN at the American Society
Regeneron Pharmaceuticals, Inc. announced positive Phase 2 trial results for two novel factor XI antibodies, REGN7508Cat and REGN9933A2, showing robust
BridgeBio Pharma presented data from the ATTRibute-CM study showing acoramidis reduces all-cause mortality by 59% in the overall variant ATTR-CM
Ionis Pharmaceuticals Inc. announced positive results from Phase 3 studies of olezarsen in patients with severe hypertriglyceridemia, showing up to
PENN Entertainment (NASDAQ:PENN) missed revenue expectations in Q3 CY2025 with sales rising 4.8% to $1.72 billion. Non-GAAP loss was $0.22
Quantum computing aims to revolutionize computer power by using qubits instead of traditional bits, potentially solving problems in minutes that
CRISPR Therapeutics announced positive Phase 1 data for CTX310®, a gene-editing therapy targeting ANGPTL3, showing significant reductions in ANGPTL3, triglycerides,
